InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
0.00%
)
Bitcoin
60,736.38
(
-0.25%
)
Post# of 252431
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 832
Posts 119956
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 174235

Monday, 03/03/2014 2:33:03 PM

Monday, March 03, 2014 2:33:03 PM

Post# of 252431
OHRP reaches into the back vaults for Trodusquemine, once a purported anti-obesity compound owned by Genaera, and brings in Cold Springs Harbor as a JV partner:

http://finance.yahoo.com/news/ohr-pharmaceutical-cold-spring-harbor-100000356.html

Between Squalamine eye drops and the Trodusquemine JV announced today, OHRP appears to be hoping that today’s biotech investors don’t remember Genaera.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up